These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 126568)

  • 1. [The preparation and characterization of transfer factor (author's transl)].
    Schröder I; Werner H; Lorenz U; Köhler H; Jenssen HL
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):365-71. PubMed ID: 126568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro determination of effects of dialyzable leukocyte extracts containing transfer factor activity.
    Schroder I; Rovensky J
    Allergol Immunopathol (Madr); 1982; 10(3):171-6. PubMed ID: 7148610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation of soluble tumor-associated antigens of human malignant melanoma].
    Suter L
    Fortschr Med; 1978 Aug; 96(32):1615-8. PubMed ID: 680624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfer factor--a lymphocyte cell surface component.
    Schröder I; Lüneburg S
    Allergol Immunopathol (Madr); 1984; 12(1):1-5. PubMed ID: 6731201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. V. Antigen-specific lymphocyte responsiveness can be initiated by two structurally distinct polyribonucleopeptides.
    Wilson GB; Paddock GV; Fudenberg HH
    Thymus; 1981 Feb; 2(4-5):257-6. PubMed ID: 6165106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human transfer factor on the migration of guinea-pig macrophages: is there an antigen-specific activity?
    Sargent IL; Salaman MR
    Immunology; 1980 Sep; 41(1):227-35. PubMed ID: 6159314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate.
    Qi HY; Wan ZF; Su CZ
    Acta Virol; 1992 May; 36(3):231-8. PubMed ID: 1360750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.
    Nékám K; Kalmár L; Gergely P; Kelemen G; Fekete B; Láng I; Lévai J; Petrányi GY
    Clin Exp Immunol; 1977 Mar; 27(3):416-20. PubMed ID: 324669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human transfer factor in vitro. II. Augmentation of the secretion of leucocyte migration inhibitory factor (LIF) by leucocyte dialysate and by its components L-serine and glycine.
    Ashorn RG; Räsänen L; Marnela KM; Krohn KJ
    Clin Exp Immunol; 1979 Jul; 37(1):50-7. PubMed ID: 385187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of antigen-dependent macrophage migration inhibition factor (MIF) from lymph draining a tuberculin reaction.
    Scott DM; McConnell I; Agomo P; Lachmann PJ
    Immunology; 1978 Apr; 34(4):591-604. PubMed ID: 363599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of murine antigen-specific transfer factor of defined potency.
    Mayer V; Valásková M; Gajdosová E; Oravec C
    Acta Virol; 1983 May; 27(3):228-37. PubMed ID: 6138984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modification of delayed type hypersensitivity by small molecular weight components derived from human leucocytes: partial purification of components causing amplification of response.
    Gottlieb AA; Sutcliffe SB
    Clin Exp Immunol; 1982 Nov; 50(2):434-41. PubMed ID: 6185262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human transfer factor prepared by dialysis, ultrafiltration and gel chromatography: biological activity in local transfer of skin sensitivity.
    Lawton JW; Darg C; Pepper D; Kay AB
    J Immunol Methods; 1977; 16(2):119-29. PubMed ID: 881554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivities.
    Burger DR; Vandenbark AA; Dunnick W; Kraybill W; Daves GD; Vetto RM
    J Immunol; 1979 Mar; 122(3):1091-8. PubMed ID: 448071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human transfer factor. I. Production by the great pool technic and the biochemical and immunological characteristics of the preparation].
    Karl M; Metzner G; Franke W; Vogelsang H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):9-23. PubMed ID: 6192059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Technics and applications of transfer factor (author's transl)].
    Edelman L; Reviron J
    Pathol Biol (Paris); 1979 Dec; 27(10):647-8. PubMed ID: 395495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation of beta2-microglobulin from transfer factor in dialyzable leukocyte extracts.
    Nékám K; Kelemen GS; Varró R; Fekete B; Láng I; Kalmár L; Gergely P; Petrányi G
    Allerg Immunol (Leipz); 1978; 24(4):254-8. PubMed ID: 84525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The current position of the transfer factor investigation (author's transl)].
    Schröder I
    Allerg Immunol (Leipz); 1978; 24(4):243-53. PubMed ID: 154287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractionation studies on human leucocyte dialyzates. Demonstration of three components with transfer factor activity.
    Krohn K; Gröhn P; Horsmanheimo M; Virolainen M
    Med Biol; 1976 Dec; 54(5):334-40. PubMed ID: 994567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
    Luben RA; Mundy GR; Trummel CL; Raisz LG
    J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.